£1,190
−24%vs May 2024Active - Proposal to Strike off10180388Private limited companyLondon
GLIALIGN LIMITED
Significant control: Ucl Business PLC (25–50%)
Proposal to strike offThe registrar has published a notice proposing to remove this company from the register. Unless the cause is dealt with or an objection is upheld, it can be dissolved. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Glialign Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
GLIALIGN LIMITED is an active (proposal to strike off) private limited company (company number 10180388) incorporated on 14 May 2016, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 May 2025, showing net assets of £1,190, with 0 employees on average. Turnover was £0 and profit for the year −£483. Net assets fell 24% on the prior period (£1,573).
Peer position · net assets
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Ucl Business Plc
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr John David Sinden
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 14 May 201610 yrs ago
- Next accounts due
- 28 February 2027in 128 days
- Confirmation statement due
- 28 May 2027in 217 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
£0
Not reported the period before0
Not reported the period before| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £1,190 | — | — | £483 | £0 | −£483 | 0 |
| 31 May 2024 | £1,573 | — | — | £483 | — | — | — |
Current ratio3.46Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,190 at 31 May 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 3.46
- Incorporated five or more years agoIncorporated 14 May 2016
- Register status is not ActiveActive - Proposal to Strike off
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 217 days
- Next accounts duein 128 days
- Accounts period endNet assets £1,190 · micro accounts
- Accounts period endNet assets £1,573 · micro accounts
- Incorporated
08
Similar companies in London
- SPERO CANTAB UK LIMITEDLondon · inc. May 2016
- EVERNA LIMITEDLondon · inc. May 2016
- JULES M GROUP LIMITEDLondon · inc. Apr 2016
- CONTINUUM LIFE SCIENCES LIMITEDLondon · inc. Apr 2016
- GYROSCOPE THERAPEUTICS LIMITEDLondon · inc. Apr 2016
- ELEUSIS THERAPEUTICS LTDLondon · inc. Jun 2016
All companies incorporated on 14 May 2016 · in May 2016.
09
Reminders for GLIALIGN LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.